Synonyms: ETX-2514 | EXT2514 | Xacduro® (sulbactam and durlobactam)
durlobactam is an approved drug (FDA (2023))
Compound class:
Synthetic organic
Comment: Durlobactam (ETX2514) is a broad-spectrum diazabicyclooctanone (DBO) class non-beta-lactam beta-lactamase inhibitor [1]. It reduces beta-lactamase-mediated degradation of beta-lactam antibacterials, and has been demonstrated to restore sulbactam activity against Acinetobacter species, including contemporary multidrug-resistant strains [4]. There is evidence that a few carbapenem- and colistin-resistant, metallo beta-lactamase (MBL)-producing strains of A. baumannii are resistant to sulbactam/durlobactam dual therapy [2,5].
|
|
Bioactivity Comments |
Durlobactam has potent in vitro activity against clinically relevant class A, C and D serine beta-lactamases (IC50 = 4-190 nM) [1]. |